Please find enclosed

September 30, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 SCRIP CODE: 543748 SYMBOL: AARTIPHARM Dear Sir/Madam, Sub: Intimation under Regulation 30 of SEBI Listing Regulations- Reconstitution of Committee of the Board of Directors Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, on September 30, 2026, approved the reconstitution of the Nomination and Remuneration Committee of the Company, with effect from October 01, 2026. The composition of the reconstituted committee, effective from October 01, 2026, is as follows: Nomination and Remuneration Committee Sr No. Name of Committee Member Position Category 1. Smt. Jeenal Savla Chairperson Independent Director 2. Dr. Vinay Nayak Member Independent Director 3. Shri Pradeep Thakur Member Independent Director 4. Shri Rashesh Gogri Member Executive Director Please take note of the above on your record. Thanking you, Yours faithfully, For AARTI PHARMALABS LIMITED JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565